133 related articles for article (PubMed ID: 26462261)
1. Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
Takeda Y; Doyama H; Tsuji K; Yamada S; Takemura K
BMJ Open Gastroenterol; 2014; 1(1):e000003. PubMed ID: 26462261
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly japanese patients: is it really necessary or not?
Nakamura N; Yoneda K; Higo T; Kusumoto M
J Pharm Health Care Sci; 2022 Dec; 8(1):35. PubMed ID: 36514145
[TBL] [Abstract][Full Text] [Related]
3. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
Cundy T; Dissanayake A
Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
Hughes J; Y Y Chiu D; Kalra PA; Green D
PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
[TBL] [Abstract][Full Text] [Related]
5. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
Misra PS; Alam A; Lipman ML; Nessim SJ
BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
[TBL] [Abstract][Full Text] [Related]
6. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
[TBL] [Abstract][Full Text] [Related]
7. Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients.
Douwes RM; Gomes-Neto AW; Schutten JC; van den Berg E; de Borst MH; Berger SP; Touw DJ; Hak E; Blokzijl H; Navis G; Bakker SJL
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817776
[TBL] [Abstract][Full Text] [Related]
8. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
10. Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.
Hess MW; de Baaij JH; Broekman M; Bisseling TM; Haarhuis B; Tan A; Te Morsche R; Hoenderop JG; Bindels RJ; Drenth JP
Aliment Pharmacol Ther; 2016 Jun; 43(11):1178-85. PubMed ID: 27086738
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
13. Systematic review: hypomagnesaemia induced by proton pump inhibition.
Hess MW; Hoenderop JG; Bindels RJ; Drenth JP
Aliment Pharmacol Ther; 2012 Sep; 36(5):405-13. PubMed ID: 22762246
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
[TBL] [Abstract][Full Text] [Related]
15. Uses of proton pump inhibitors and hypomagnesemia.
Gau JT; Yang YX; Chen R; Kao TC
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
[TBL] [Abstract][Full Text] [Related]
16. Effect of proton pump inhibitors on magnesium balance: is there a link to cardiovascular risk?
Pisani LF; Filippi E; Vavassori S; Munizio N; Vecchi M; Pastorelli L
Magnes Res; 2016 Mar; 29(1):1-10. PubMed ID: 27086964
[TBL] [Abstract][Full Text] [Related]
17. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.
Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H
Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor associated hypomagnasaemia - a cause for concern?
Begley J; Smith T; Barnett K; Strike P; Azim A; Spake C; Richardson T
Br J Clin Pharmacol; 2016 Apr; 81(4):753-8. PubMed ID: 26613375
[TBL] [Abstract][Full Text] [Related]
19. Short-term proton pump inhibitor treatment may cause hypomagnesaemia in critically ill patients - a pilot study.
Krzych ŁJ; Łój P; Nowak T; Kazura W; Knapik P
Acta Biochim Pol; 2017; 64(3):499-501. PubMed ID: 28651024
[TBL] [Abstract][Full Text] [Related]
20. [Severe hypomagnesaemia due to proton pump inhibitor use].
van den Berg S; Scheer MLJ; Holman ND
Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
